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Purpose: To report a case of Wolfram syndrome characterized by early onset diabetes 
mellitus and progressive optic atrophy.
Case Report: A 20-year-old male patient with diabetes mellitus type I presented with 
best corrected visual acuity of 1/10 in both eyes with correction of -0.25+1.50@55 and         
-0.25+1.50@131 in his right and left eyes, respectively. Bilateral optic atrophy was 
evident on fundus examination. The patient also had diabetes insipidus, neurosensory 
deafness, neurogenic bladder, polyuria and extra-residual voiding indicating atony 
of the urinary tract, combined with delayed sexual maturity.
Conclusion: One should consider Wolfram syndrome in patients with juvenile onset 
diabetes mellitus and hearing loss. Ophthalmological examination may disclose optic 
atrophy; urologic examinations are vital in such patients.
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INTRODuCTION 
Wolfram syndrome (WS) is an autosomal recessive 
neurodegenerative disorder characterized by 
early onset diabetes mellitus and progressive 
optic atrophy in the first decade of life.1,2 This 
condition is also known as DIDMOAD syndrome, 
an acronym composed of diabetes insipidus 
(DI), diabetes mellitus (DM), optic atrophy 
(OA) and deafness (D).3 In 1938, Wolfram et al,4 
described eight siblings from a family of whom 
four had diabetes mellitus and optic atrophy. 
Subsequently three of these four subjects 
developed sensorineural hearing loss, and 
two developed a neurogenic bladder. Minimal 
criteria for establishing the diagnosis are diabetes 
mellitus and optic atrophy. Diabetes insipidus, 
sensorineural deafness, urinary tract atony, ataxia, 
peripheral neuropathy, mental retardation and 
psychiatric disorders are additional findings 
present in the majority of patients.5
The sequence of the Wolfram syndrome 
gene (WFS1) was described in 1998 and 
mutations in this gene have been reported 
in many populations. To date, the function 
of the putative protein remains unknown.5 A 
candidate gene has recently been identified on 
chromosome 4p16.1, but there is evidence of 
locus heterogeneity and a minority of patients 
may harbor a mitochondrial genome deletion.6
This syndrome should be considered in 
young diabetic patients with unexplained visual 
loss or polyuria and polydipsia in the presence 
of high blood sugar. The exact prevalence of 
Wolfram syndrome is unknown but a rate of one 
in 770,000 as estimated in a UK study,7 where a 
physician might see one or two cases in his or 
her working life time, seems realistic. Although 
there is a high prevalence of consanguineous 
marriages in the Middle East and North Africa, 
only few cases of Wolfram syndrome have been 
reported from these regions. It may therefore 
be reasonable to assume that the condition is 
under-reported from this part of the world. Wolfram Syndrome; Naderian et al
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A 20-year-old male patient, a known case of 
diabetes mellitus type I from 7 years before, 
presented to a private ophthalmology office. 
His blood sugar was inadequately controlled 
even with insulin injections. His parents were 
consanguineous but healthy, however his 
grandparents were diabetic. Best-corrected visual 
acuity was 1/10 in both eyes with -0.25+1.50@55 
and -0.25+1.50@131 in his right and left eyes 
respectively. Intraocular pressure was 14 mmHg 
in both eyes and biomicroscopic examinations 
were completely normal. Fundus examination 
showed advanced bilateral optic atrophy but 
no sign of diabetic retinopathy (Figures 1, 2). 
Laboratory studies and dehydration test 
confirmed diabetes insipidus. An audiologic 
examination revealed neurosensory deafness. 
Magnetic resonance imaging (MRI) of the brain 
and lumbar spine was normal. Both kidneys 
were larger than normal and showed signs of 
moderate hydronephrosis on ultrasonographic 
evaluation. The bladder wall had a trabecular 
pattern and the urinary tract was dilated on 
both sides. The patient had 170 ml post-voiding 
bladder residue. Urologic examination and 
sonographic findings were consistent with a 
neurogenic bladder (Figure 3). The patient also 
had polyuria and extra-residual voiding which 
indicated atony of the urinary tract. Urogenital 
examination revealed some degree of delayed 
sexual maturation.
DISCuSSION 
Wolfram syndrome is a progressive autosomal 
recessive neurodegenerative disorder.1 
Hallmarks of the syndrome are diabetes mellitus, 
which is usually the first sign of the disease 
(median age at diagnosis, 6–15 years), and optic 
atrophy (median age at diagnosis 11 years). 
Optic atrophy in a diabetic patient necessitates 
audiometry and intravenous pyelography.8 In 
our patient the majority of symptoms became 
manifest by the second decade of life and a 
correct diagnosis had been made when he was 
15 years old.
Hearing loss, mainly in high frequencies, 
may be present in 48% of patients and diabetes 
insipidus of hypothalamic origin may occur in 
the third decade of life in up to 75% of cases.9,10 
Dilation of the urinary tract is observed in 45% 
Figure 1. Optic atrophy in the right eye.
Figure 2. Optic atrophy in the left eye.
Figure 3.  Bladder  sonography  is  consistent  with  a 
neuorogenic bladder.Wolfram Syndrome; Naderian et al
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of cases which may be secondary to chronic high 
urine flow rates (diabetes insipidus) or neuronal 
degeneration at various levels of the urinary 
tract.11 Atony of the bladder and the whole 
urinary tract may also be observed. Additionally, 
retinal pigmentary changes, spinocerebellar 
degeneration, delayed sexual maturation, a 
small sella turcica and male hypogonadism due 
to primary gonadal failure have been reported 
with DIDMOAD syndrome.12-14
Differential diagnoses include congenital 
rubella syndrome, Leber’s hereditary optic 
atrophy, and thiamine responsive anemia with 
diabetes mellitus and deafness. The association 
of diabetes mellitus with optic atrophy also 
occurs in Friedreich’s ataxia, Refsum disease, 
Alstrom syndrome, Lawrence-Moon syndrome, 
Kearn-Sayre syndrome, and deafness and 
diabetes in the “3243” mitochondrial DNA 
mutation.8 
The pathogenesis of the disease remains 
unknown, but positional cloning studies in 
families with Wolfram syndrome have identified 
linkage peaks on the short arm of chromosome 
4 (4p16.1). Mutations in the gene encoding 
wolframin (WFS1), which maps to that region, 
have also been shown to cause the syndrome.15,16 
Nevertheless, the wide spectrum of clinical 
manifestations affecting several organs and 
tissues, suggests mitochondrial DNA (mtDNA) 
involvement. 
Since the initial identification of the WFS1 
gene by Inoue et al,17,18 different research groups 
have reported more than 50 distinct mutations 
in this gene. WFS1 protein presumably functions 
to maintain certain populations of neuronal 
and endocrine origin. Diabetes mellitus may 
result from hypothalamic degeneration, 
although loss of pancreatic β-islet cells as part 
of a specific defect in neuroectodermal amine 
precursor uptake and decarboxylation-derived 
cells in the pancreas and in the supraoptic and 
paraventricular nuclei has also been postulated. 
DI is thought to be related to atrophy and 
degeneration of the hypothalamus with loss of 
vasopressin-secreting neurons in the supraoptic 
and paraventricular nuclei, and degeneration 
of the posterior pituitary gland. The deafness is 
sensorineural and degenerative; atrophy of the 
vestibulocochlear nuclei and inferior colliculi 
may be responsible.19
Due to variability of symptoms, Wolfram 
syndrome may be overlooked. The condition 
should be evaluated in a multidisciplinary 
manner and specific tests are necessary to 
make a precise diagnosis and disclose all 
components of the syndrome. Management 
requires cooperation between several specialists 
including an endocrinologist, neurologist, 
ophthalmologist and urologist.
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